Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies
Nivesh Mittal(University of Tennessee Health Science Center), G. Christopher Wood(University of Tennessee Health Science Center)
Cited by 5